D-1112-2018 Class III Terminated
FDA drug recall D-1112-2018 was initiated by Mylan Institutional, Inc. (D.B.A. UDL Laboratories) on Aug 14, 2018 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer The recall status is terminated (terminated Jun 26, 2020). Affected quantity: 408 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 29, 2018
- Initiation Date
- Aug 14, 2018
- Termination Date
- Jun 26, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 408 cartons
Product description
Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08
Reason for recall
Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer
Distribution pattern
Nationwide USA
Code information
Batch 3096049
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1112-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026